explore -WSS

explore

author：knowledge 2025-10-02 22:27:01 - browse：3

translucent 3D DNA helix with blue and purple background — Adobe

Verve Therapeutics said Monday that it had received clearance from the Food and Drug Administration to conduct a clinical trial in the U.S. of its experimental, gene-editing treatment for a common form of heart disease.

The FDA’s action removes a clinical hold on Verve’s CRISPR-based therapy, called VERVE-101, that was placed on it last November. Verve now intends to recruit participants from U.S. sites into a Phase 1 study that’s been underway since last year in New Zealand and the United Kingdom.

“We’re thrilled to get this clearance for VERVE-101,” said Verve CEO Sek Kathiresan. “Our study is called HEART-1 and our plan now is to activate U.S. sites.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Tori Bowie and the unacceptable rates of Black maternal death
Next article： New warning issued for rebooking air travel after delays, cancellations

explore

WSS

Ebola public health emergency is over, WHO declares

HHS suspends federal funding for EcoHealth Alliance

Trump got a 'target letter.' What is one and what does it mean?

Lilly’s weekly insulin works as well as daily products, new studies show

The kidney, in all its complexity, is captured in a new atlas

TikTok cracks down on users posting about weight loss drugs

leisure time

explore

knowledge

Activists slam private health insurers over coverage restrictions

Plane’s emergency slide plummets from sky, hits Chicago home

The high cost of giving birth even with insurance

Ripples from Flovent's discontinuation is killing children with asthma

Trump demands the U.S. pay no more for drugs than other countries … again

Why some people catch Covid but never get sick

Tori Bowie and the unacceptable rates of Black maternal death

Celebrate National Dole Whip Day for 3 days this week at Disney

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

WuXi Biologics execs register to lobby as Congress comes for the company

Wikipedia

TikTok cracks down on users posting about weight loss drugs

Man who had jail sentence commuted by Trump arrested again

What a koala virus tells us about the human genome

Galapagos to make CAR

Ebola public health emergency is over, WHO declares

Seattle police shoot person suspected in downtown stabbing

explore

explore

focus

focus